Correlation between MEK signature and Ras gene alteration in advanced gastric cancer-Reference-Cited by-同舟云学术

Correlation between MEK signature and Ras gene alteration in advanced gastric cancer

Published:2017-05-23 Issue:64 Volume:8 Page:107492-107499
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ahn Soomin¹,Brant Roz²,Sharpe Alan³,Dry Jonathan R.⁴,Hodgson Darren R.²,Kilgour Elaine²,Kim Kyung⁵,Kim Seung Tae⁵,Park Se Hoon⁵,Kang Won Ki⁵,Kim Kyoung-Mee¹,Lee Jeeyun⁵

Affiliation:

1. Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

2. AstraZeneca, Oncology Innovative Medicines, Alderley Park, Macclesfield, UK

3. AstraZeneca, Cambridge, UK

4. AstraZeneca, Boston, Massachusetts, USA

5. Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer;International Journal of Molecular Sciences;2024-02-03

2. Comprehensive analysis of CPNE1 predicts prognosis and drug resistance in gastric adenocarcinoma;American Journal of Translational Research;2024

3. Optimized Transcriptional Signature for Evaluation of MEK/ERK Pathway Baseline Activity and Long-Term Modulations in Ovarian Cancer;International Journal of Molecular Sciences;2022-11-01

4. Inhibition of MACC1-Induced Metastasis in Esophageal and Gastric Adenocarcinomas;Cancers;2022-03-31

5. Optimized transcriptional signature for evaluation of MEK/ERK pathway baseline activity and long-term modulations in ovarian cancer;2022-03-23